Malaysia Diabetes Ramadan Nutrition Plan (My Dia-RNP®): A Feasibility Study
MyDia-RNP
Effects of Malaysia Diabetes Ramadan Nutrition Plan (My Dia-RNP) on Adherence, Acceptability, Efficacy Potential and Quality of Life in Patients With Type 2 Diabetes Mellitus: A Feasibility Study
1 other identifier
interventional
53
1 country
1
Brief Summary
Ramadan fasting is an important event for Muslims. During Ramadan, all healthy Muslims are asked to abstain from food and drink throughout the day and eat only during daybreak (also know as Sahur in Malay/Arabic language) and after sunset (also know as Iftar in Malay/Arabic language). Patients with type 2 diabetes (T2DM) can be exempted from fasting but most of them do not perceive themselves as sick, and they continue to fast. With so many Muslims with diabetes choosing to fast, there is an immediate need for evidence-based nutrition practice guidelines. This study is conducted to determine the feasibility of implementing the Ramadan Nutrition Plan named My Dia-RNP that is also incorporating diabetes-specific nutrition formula on dietary adherence and acceptability in patients with type 2 diabetes mellitus. We hypothesized that My Dia-RNP is feasible to be practiced by patients with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Apr 2019
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2019
CompletedFirst Posted
Study publicly available on registry
January 25, 2019
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedAugust 12, 2019
August 1, 2019
8 months
January 9, 2019
August 9, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of participants completed the study
The ability and likelihood to complete a study successfully with the aim to achieve at least 80% of the study retention rates.
12 weeks
Secondary Outcomes (7)
Rate of participants adhered to the intervention
12 weeks
Efficacy potential on the rate of hypoglycemia
12 weeks
Efficacy potential on the fructosamine level
4 weeks
Efficacy potential on fasting glucose
12 weeks
Efficacy potential on glycemic control
12 weeks
- +2 more secondary outcomes
Study Arms (2)
My Dia-RNP
EXPERIMENTALIn the My Dia-RNP group, participants will undergo the pre-RNP assessment 2 weeks before Ramadan. They will be given a nutrition education based on the Ramadan Nutrition Plan Guide published by IDF-DAR Practical Guidelines. They will also be asked to incorporate diabetes-specific nutrition formula (Nutren untuk Diabetik®) within the prescribed calories before Ramadan period to help them familiarise with a dietary change.
Usual Care
ACTIVE COMPARATORParticipant in this group will continue in a usual care (UC) group. They will receive dietary advice based on the Practical Guide to Diabetes Management in Ramadan produced by Ministry of Health (2015).
Interventions
Subjects in this group will be advised to follow My Dia-RNP and to incorporate diabetes-specific formula (Nutren®Untuk Diabetik)
Eligibility Criteria
You may qualify if:
- All Muslim patients aged \> 18 years old
- Have a confirmed diagnosis of T2D for at least 6 months
- BMI \> 18.5 but \< 40 kg/m2
- HbA1c of \> 6.5% but \< 10%
- On a stabilised dose of oral anti-diabetes agents (OAD) for the past 2 months prior to the study
- Willing to fast for at least 15 days during Ramadan
You may not qualify if:
- History of hypoglycaemia leading to hospitalization during the previous Ramadan
- Liver disease
- Abnormal liver function test or renal profiles
- On insulin injection
- Reported abnormal thyroid stimulating hormones
- Use of medications known to effect lipid or glucose metabolism such as steroid
- Pregnancy or the desire to become pregnant in the next 3 months
- On any weight loss program or weight loss medications
- History of cancer undergoing active treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universiti Putra Malaysialead
- Nestle Health Sciencecollaborator
- Joslin Diabetes Centercollaborator
Study Sites (1)
Universiti Putra Malaysia
Serdang, Selangor, 43400, Malaysia
Related Publications (11)
Babineaux SM, Toaima D, Boye KS, Zagar A, Tahbaz A, Jabbar A, Hassanein M. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med. 2015 Jun;32(6):819-28. doi: 10.1111/dme.12685. Epub 2015 Apr 10.
PMID: 25581456BACKGROUNDBujang MA, Ismail M, Hatta NKBM, Othman SH, Baharum N, Lazim SSM. Validation of the Malay version of Diabetes Quality of Life (DQOL) Questionnaire for Adult Population with Type 2 Diabetes Mellitus. Malays J Med Sci. 2017 Aug;24(4):86-96. doi: 10.21315/mjms2017.24.4.10. Epub 2017 Aug 18.
PMID: 28951693BACKGROUNDCampbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000 Sep 16;321(7262):694-6. doi: 10.1136/bmj.321.7262.694. No abstract available.
PMID: 10987780BACKGROUNDHamdy O, Barakatun-Nisak MY. Nutrition in Diabetes. Endocrinol Metab Clin North Am. 2016 Dec;45(4):799-817. doi: 10.1016/j.ecl.2016.06.010.
PMID: 27823606BACKGROUNDLee JY, Wong CP, Tan CSS, Nasir NH, Lee SWH. Type 2 diabetes patient's perspective on Ramadan fasting: a qualitative study. BMJ Open Diabetes Res Care. 2017 May 8;5(1):e000365. doi: 10.1136/bmjdrc-2016-000365. eCollection 2017.
PMID: 28761651BACKGROUNDLee SWH, Lee JY, Tan CSS, Wong CP. Strategies to Make Ramadan Fasting Safer in Type 2 Diabetics: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Observational Studies. Medicine (Baltimore). 2016 Jan;95(2):e2457. doi: 10.1097/MD.0000000000002457.
PMID: 26765440BACKGROUNDLee JY, Wong CP, Tan CSS, Nasir NH, Lee SWH. Telemonitoring in fasting individuals with Type 2 Diabetes Mellitus during Ramadan: A prospective, randomised controlled study. Sci Rep. 2017 Aug 31;7(1):10119. doi: 10.1038/s41598-017-10564-y.
PMID: 28860546BACKGROUNDLessan N, Hannoun Z, Hasan H, Barakat MT. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab. 2015 Feb;41(1):28-36. doi: 10.1016/j.diabet.2014.11.004. Epub 2014 Dec 10.
PMID: 25497966BACKGROUNDSalti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004 Oct;27(10):2306-11. doi: 10.2337/diacare.27.10.2306.
PMID: 15451892BACKGROUNDHassanein M, Al-Arouj M, Hamdy O, Bebakar WMW, Jabbar A, Al-Madani A, Hanif W, Lessan N, Basit A, Tayeb K, Omar M, Abdallah K, Al Twaim A, Buyukbese MA, El-Sayed AA, Ben-Nakhi A; International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance. Diabetes and Ramadan: Practical guidelines. Diabetes Res Clin Pract. 2017 Apr;126:303-316. doi: 10.1016/j.diabres.2017.03.003. Epub 2017 Mar 12.
PMID: 28347497BACKGROUNDJadviscokova T, Fajkusova Z, Pallayova M, Luza J, Kuzmina G. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Dec;151(2):263-6. doi: 10.5507/bp.2007.044.
PMID: 18345261BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barakatun-Nisak Mohd Yusof, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Wan Zul Haikal Hafiz Wan Zukiman, Mmed
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Noraida Omar, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Zalina Abu Zaid, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Azrina Azlan, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Firdaus Mamat @ Mukhtar, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Norhasmah Sulaiman, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Siti NurA'syura Adznam, PhD
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Nur Maziah Hanum Osman, Master
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Nor Farahain Yahya, Degree
Universiti Putra Malaysia
- PRINCIPAL INVESTIGATOR
Osama Hamdy, MD, PhD
Joslin Diabetes Centre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 9, 2019
First Posted
January 25, 2019
Study Start
April 1, 2019
Primary Completion
December 1, 2019
Study Completion
December 30, 2019
Last Updated
August 12, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share
The data is subjected to privacy